CPMI-0721 - Metric # 46 | P2Y12- Inhibitor at Discharge-0721 - Metric # 46

0721 - Metric # 46 | P2Y12- Inhibitor at Discharge

Video Transcription

Video Summary

In this video, the Chest Pain MI Registry presents a case scenario involving a patient with a history of hypertension, CAD, and hyperlipidemia presenting with chest pain and diaphoresis. The patient's ECG confirms NSTEMI, and the cardiologist opts for medical treatment instead of PCI. There is a discussion about changing the patient's P2Y12 inhibitor from Prasugrel to Ticagrelor, but the patient refuses. The patient is discharged with an increased dose of Atavastatin but no change in P2Y12 inhibitor. The question posed is how to code the discharge medications for Ticagrelor and Clopidogrel, with the answer being "no patient reason." The video also explains the metrics and exceptions related to P2Y12 inhibitor use at discharge. The patient in this scenario is an exception due to being medically treated with Prasugrel for their enstemi diagnosis. The video concludes by acknowledging the support of the Chest Pain MI Registry Steering Committee for this exception.

Keywords

Chest Pain MI Registry

NSTEMI

P2Y12 inhibitor

Prasugrel

Ticagrelor